Evidence map›Paper›PMID 40977277›Full record

ArticleJournal of cell science2025

Differential splice isoforms of mouse CDK2 play functionally redundant roles during mitotic and meiotic division.

Nathan Palmer, Nisan Ece Kalem-Yapar, Hanna Hultén, Umur Keles, S Zakiah A Talib, Jin Rong Ow, Tommaso Tabaglio, Christine M F Goh, Li Na Zhao, Ernesto Guccione and 2 more

Abstract read
In one paragraph

Article in Journal of cell science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nathan PalmerDepartment of Chromosome Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter, Vienna 1030, Austria.ORCID 0000-0002-1913-9454
Nisan Ece Kalem-YaparDepartment of Clinical Sciences, Lund University, Clinical Research Centre (CRC), Box 50332, SE-202 13 Malmö, Sweden.ORCID 0000-0001-5895-2459
Hanna HulténDepartment of Clinical Sciences, Lund University, Clinical Research Centre (CRC), Box 50332, SE-202 13 Malmö, Sweden.ORCID 0009-0007-4763-5782
Umur KelesDepartment of Clinical Sciences, Lund University, Clinical Research Centre (CRC), Box 50332, SE-202 13 Malmö, Sweden.ORCID 0000-0002-6771-3721
S Zakiah A TalibBiozentrum der LMU München, Department Biologie II, Zell- und Entwicklungsbiologie, 82152 Planegg-Martinsried, Germany.ORCID 0000-0002-6063-254X
Jin Rong OwInstitute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.ORCID 0000-0002-7468-691X
Tommaso TabaglioInstitute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.ORCID 0000-0001-6873-3073
Christine M F GohInstitute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.
Li Na ZhaoDepartment of Clinical Sciences, Lund University, Clinical Research Centre (CRC), Box 50332, SE-202 13 Malmö, Sweden.ORCID 0000-0001-6552-0929
Ernesto GuccioneCenter for OncoGenomics and Innovative Therapeutics (COGIT), Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.ORCID 0000-0001-7764-5307
Kui LiuDepartment of Obstetrics and Gynecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID 0000-0002-7519-3332
Philipp KaldisDepartment of Clinical Sciences, Lund University, Clinical Research Centre (CRC), Box 50332, SE-202 13 Malmö, Sweden.ORCID 0000-0002-7247-7591

Funding

Cancerfonden 21-1566PjCancerfonden 24-3605PjCrafoordska Stiftelsen 20220628Lunds UniversitetShenzhen Science and Technology Innovation Program KQTD20190929172749226Stiftelsen för Strategisk Forskning Dnr 2009-1039Stiftelsen för Strategisk Forskning Dnr IRC15-0067Vetenskapsradet 2021-01331Vetenskapsradet EXODIAB Dnr 2009-1039Vetenskapsrådet 2021-01331
6 · The paper itself

Abstract

In most mammals, the cell cycle kinase cyclin-dependent kinase 2 (CDK2) is expressed as two major isoforms as a result of alternative splicing. The shorter CDK2 isoform, CDK2S, is expressed constitutively during the cell cycle and can be detected in several tissues. In contrast, the longer isoform, CDK2L, shows preferential expression in meiotically dividing cells and upon S-phase entry in the mitotic cycle. Both CDK2L and CDK2S form heteromeric complexes with cyclins A2 and E1 in vitro. However, complexes composed of each isoform differ considerably in their kinase activity towards known CDK substrates. It is currently unknown whether the long and short isoforms of CDK2 play functionally different roles in vivo during either mitotic or meiotic divisions as conventional knockout methodology deletes both of the isoforms. Therefore, we generated mice expressing only CDK2S or CDK2L and found that both CDK2L and CDK2S are sufficient to support both mitotic and meiotic division when expressed in the absence of the other. These data contribute to the explanation of the apparent tolerance of the evolutionary loss of CDK2L expression in humans.

Indexed as

Alternative SplicingCyclin-Dependent Kinase 2MeiosisMitosisAnimalsHumansIsoenzymesMiceProtein IsoformsCdk2 protein, mouseCyclin-Dependent Kinase 2IsoenzymesProtein IsoformsCDK2Gene functionMeiosisMitosisMouseSplicing

Identifiers

PMID40977277
PMCPMC12539205

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.